Description
Molecules, Cells, and Parasites in Immunology contains the proceedings of a symposium on immunology held in Mexico City in the fall of 1979 under the auspices of the National University of Mexico (UNAM). This volume brings together prominent foreign scientists and Mexican investigators to discuss the areas of immunology that being developed at UNAM.
Either in the form of reviews or of original presentations, the various authors proffer observations and ideas that generally relate to the regulation of the immune response at the molecular and cellular levels. The topic of Molecules encompasses the effect of molecular aggregation upon the triggering of physiological events, cooperative binding, and the expression of immunoglobulins during the lymphocyte differentiation process. Under the heading of Cells, there are contributions dealing with the physiological and pathological roles of interiorized antibodies; the mechanisms of antigen recognition by T cells; and the synthesis of membrane proteins by myeloma cells which somehow protect them from killer T cells. The section on Parasites includes some unique contributions on the immunology of human and animal cysticercosis and amebiasis, complemented by a general discussion of host-parasite relationships.
Chapter
CHAPTER 1. MOLECULAR MECHANISMS OF ANTIBODY ACTION: USE OF CROSS-LINKING REAGENTS
III. CONCLUDING STATEMENT
CHAPTER 2.
MEMBRANE-RECEPTOR MECHANISMS IN ANAPHYLAXIS
I. THE CONCEPT OF A RECEPTOR
II. EXCITABLE TISSUE ANAPHYLAXIS
III. CONNECTIVE TISSUE INVOLVEMENT
IV. TWO DISTINCT RECEPTOR COMPONENTS
CHAPTER 3.
COOPERATIVITY AND ANTIBODY FUNCTION
III. COOPERATIVITY OR ARTIFACT?
IV. ESTIMATION OF THE PARAMETERS OF COOPERATIVITY
CHAPTER 4.
DIFFERENTIATION OF THE B-LYMPHOCYTE
II. GENERATION OF B-LYMPHOCYTES
V. DEVELOPMENT OF HEAVY CHAIN CLASS (ISOTYPE) HETEROGENEITY
VI. THE PROBLEM OF MULTIPLE CLASS REPRESENTATION
VIII. MODE OF MEMBRANE INSERTION OF SURFACE IMMUNOGLOBULIN
CHAPTER 5. ANTIBODY PENETRATION INTO LIVING CELLS:
MECHANISMS AND CONSEQUENCES
II. ANTIBODY PENETRATION AND THE Fc RECEPTOR
III. EVIDENCE OF ANTIBODY PENETRATION IN VIVO
IV. CONSEQUENCES OF ANTIBODY PENETRATION
V. ROLE OF ANTIBODY PENETRATION IN IMMUNOBIOLOGY
CHAPTER 6. LAMBDA LIGHT CHAINS
AND IDIOTYPE-BEARING T CELLS
IV. DEPENDENCE OF THE SPECIFICITY OF ANTI-Id ANTIBODIES ON VL DOMAINS OF THE Id-BEARING MOLECULE
CHAPTER 7. CELLULAR RECOGNITION IN TUMOR IMMUNOLOGY: TUMOR RESISTANCE TO IMMUNE DESTRUCTION
BY CYTOTOXIC T LYMPHOCYTES
II. MATERIALS AND METHODS
II. CHEMOTAXIS: GENERAL AND TECHNICAL CONSIDERATIONS
III. CHEMOTAXIS IN HUMAN NEWBORNS AND AMEBIASIS
CHAPTER 9. BIOCHEMICAL CHARACTERIZATION OF LYMPHOCYTE MEDIATOR-MACROPHAGE INTERACTIONS
II. RESULTS AND DISCUSSION
CHAPTER 10. B LYMPHOCYTE STIMULATION BY PARASITIC ORGANISMS
CHAPTER 11. THE IMMUNOLOGY OF HUMAN CYSTICERCOSIS
II. IMMUNODIAGNOSIS OF BRAIN CYSTICERCOSIS
IV. HUMORAL IMMUNE RESPONSE
V. IMMUNITY TO CYSTICERCOSIS
VI. CELLULAR IMMUNE RESPONSE
VII. HOST-PARASITE INTERFACE
CHAPTER 12.
IMMUNOPATHOLOGY OF CYSTICERCOSIS
I. HOST-PARASITE SPECIFICITY
II. ULTRASTRUCTURE OF THE PARASITE SURFACE
IIII. SYNTHESIS OF PARASITE PROTEINS
CHAPTER 13.
IMMUNOLOGY OF AMEBIASIS
II. HUMORAL IMMUNE REACTIONS
III. CELLULAR IMMUNE REACTIONS
IV. IMMUNITY AND ANTIAMEBIC IMMUNIZATION
CHAPTER 14.
THE HOST-PARASITE INTERACTION
II. SUSCEPTIBILITY TO INFECTION
III. IMMUNOSUPPRESSION AND IMMUNOPOTENTIATION
CHAPTER 15.
THE ROLE OF CIRCUMSTANCE IN IMMUNITY
II. CIRCUMSTANCE AND IMMUNITY AT THE LEVEL OF A COMMUNITY
III. CIRCUMSTANCE AND IMMUNITY AT THE LEVEL OF AN ORGANISM
IV. CIRCUMSTANCE AT THE CELLULAR LEVEL
V. CIRCUMSTANCE AT THE MOLECULAR LEVEL
CHAPTREC 16. HEMICAL SYNTHESIS FOR THE UNDERSTANDING OF IMMUNE RESPONSE PHENOMENA AND FOR THEIR MEDICAL APPLICATION
II. SYNTHETIC ANTIGENS WITH PEPTIDE DETERMINANTS OF DEFINED SEQUENCE
III. SYNTHETIC PEPTIDE OF CARCINOEMBRYONIC ANTIGEN OF THE COLON
IV. SUPPRESSION OF EAE AND POSSIBLY OF MULTIPLE SCLEROSIS WITH A BASIC SYNTHETIC COPOLYMER
V. ANTIVIRAL EFFECT ON MS-2 COLIPHAGE OBTAINED WITH A SYNTHETIC ANTIGEN
VI. CHALLENGE OF THE COMBINED USE OF SYNTHETIC ANTIGENS AND SYNTHETIC ADJUVANTS